$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000139681420000045 Filed on October 30, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$131.0M	$117.5M	$122.4M
YoY Change	6.98%	12.23%	28.71%
Cost Of Revenue	$35.30M	$29.99M	$31.90M
YoY Change	10.64%	34.47%	33.05%
Gross Profit	$95.68M	$87.49M	$90.52M
YoY Change	5.7%	6.2%	27.25%
Gross Profit Margin	73.05%	74.47%	73.94%
Selling, General & Admin	$52.80M	$52.56M	$54.20M
YoY Change	-2.58%	4.85%	21.52%
% of Gross Profit	55.19%	60.08%	59.88%
Research & Development	$15.30M	$14.65M	$19.70M
YoY Change	-22.34%	-27.67%	38.73%
% of Gross Profit	15.99%	16.75%	21.76%
Depreciation & Amortization	$5.060M	$3.100M	$5.090M
YoY Change	-0.59%	-13.89%	25.37%
% of Gross Profit	5.29%	3.54%	5.62%
Operating Expenses	$70.10M	$67.21M	$120.7M
YoY Change	-41.93%	-34.28%	45.69%
Operating Profit	$25.58M	$17.62M	-$30.19M
YoY Change	-184.71%	630.21%	157.69%
Interest Expense	-$6.400M	$7.132M	-$4.300M
YoY Change	48.84%	20.07%	13.16%
% of Operating Profit	-25.02%	40.48%
Other Income/Expense, Net	$300.0K	-$11.47M	-$900.0K
YoY Change	-133.33%	39.39%	350.0%
Pretax Income	$12.70M	$6.150M	-$3.500M
YoY Change	-462.86%	-205.74%	-142.17%
Income Tax	-$1.800M	-$124.0M	$1.300M
% Of Pretax Income	-14.17%	-2016.26%
Net Earnings	$14.51M	$130.1M	-$4.888M
YoY Change	-396.93%	-2237.65%	-159.0%
Net Earnings / Revenue	11.08%	110.75%	-3.99%
Basic Earnings Per Share	$0.33	$3.03	-$0.12
Diluted Earnings Per Share	$0.32	$2.94	-$0.12
COMMON SHARES
Basic Shares Outstanding	43.44M shares	42.93M shares	41.73M shares
Diluted Shares Outstanding		44.28M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$521.7M	$532.1M	$292.0M
YoY Change	78.66%	100.34%	-23.86%
Cash & Equivalents	$99.96M	$125.2M	$78.23M
Short-Term Investments	$421.7M	$406.9M	$213.7M
Other Short-Term Assets	$12.30M	$11.70M	$10.80M
YoY Change	13.89%	12.5%	36.71%
Inventory	$64.65M	$68.54M	$58.30M
Prepaid Expenses
Receivables	$53.05M	$46.14M	$47.53M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$651.6M	$658.5M	$408.6M
YoY Change	59.49%	73.82%	-14.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$136.7M	$125.5M	$104.7M
YoY Change	30.58%	19.71%	-3.67%
Goodwill	$99.55M	$99.50M	$99.55M
YoY Change	0.0%	-0.05%	60.46%
Intangibles	$96.52M	$98.49M	$104.4M
YoY Change	-7.54%	-7.4%
Long-Term Investments	$109.5M	$12.80M	$10.00M
YoY Change	995.0%	-84.41%	-75.0%
Other Assets	$106.2M	$104.1M
YoY Change
Total Long-Term Assets	$622.9M	$561.7M	$422.5M
YoY Change	47.43%	31.05%	99.88%
TOTAL ASSETS
Total Short-Term Assets	$651.6M	$658.5M	$408.6M
Total Long-Term Assets	$622.9M	$561.7M	$422.5M
Total Assets	$1.275B	$1.220B	$831.1M
YoY Change	53.36%	51.12%	20.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.43M	$13.01M	$12.80M
YoY Change	-18.5%	-19.02%	-10.92%
Accrued Expenses	$70.97M	$60.40M	$70.43M
YoY Change	0.78%	-0.98%	53.55%
Deferred Revenue
YoY Change
Short-Term Debt	$149.6M	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$149.6M
YoY Change
Total Short-Term Liabilities	$253.3M	$86.27M	$107.7M
YoY Change	135.28%	-9.98%	77.5%
LONG-TERM LIABILITIES
Long-Term Debt	$313.0M	$456.5M	$306.0M
YoY Change	2.29%	51.11%	5.3%
Other Long-Term Liabilities	$3.832M	$4.219M	$1.502M
YoY Change	155.13%	81.85%	-91.1%
Total Long-Term Liabilities	$3.832M	$4.219M	$1.502M
YoY Change	155.13%	81.85%	-91.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$253.3M	$86.27M	$107.7M
Total Long-Term Liabilities	$3.832M	$4.219M	$1.502M
Total Liabilities	$654.8M	$635.6M	$476.1M
YoY Change	37.53%	37.77%	29.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$253.9M	-$268.4M	-$399.4M
YoY Change	-36.44%	-31.97%	2.88%
Common Stock	$44.00K	$43.00K	$42.00K
YoY Change	4.76%	2.38%	2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$619.7M	$584.7M	$354.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.275B	$1.220B	$831.1M
YoY Change	53.36%	51.12%	20.56%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	$14.51M	$130.1M	-$4.888M
YoY Change	-396.93%	-2237.65%	-159.0%
Depreciation, Depletion And Amortization	$5.060M	$3.100M	$5.090M
YoY Change	-0.59%	-13.89%	25.37%
Cash From Operating Activities	$46.66M	$39.79M	$25.90M
YoY Change	80.15%	116.72%	22.05%
INVESTING ACTIVITIES
Capital Expenditures	-$14.41M	-$7.760M	-$4.500M
YoY Change	220.22%	388.05%	100.89%
Acquisitions
YoY Change
Other Investing Activities	-$67.91M	-$195.1M	-$26.30M
YoY Change	158.21%	-2802.08%	-78.25%
Cash From Investing Activities	-$82.32M	-$202.9M	-$30.80M
YoY Change	167.27%	-3703.02%	-74.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.36M	209.8M	-2.020M
YoY Change	-612.87%	14671.83%	-157.39%
NET CHANGE
Cash From Operating Activities	46.66M	39.79M	25.90M
Cash From Investing Activities	-82.32M	-202.9M	-30.80M
Cash From Financing Activities	10.36M	209.8M	-2.020M
Net Change In Cash	-25.30M	46.70M	-6.920M
YoY Change	265.61%	83.79%	-92.97%
FREE CASH FLOW
Cash From Operating Activities	$46.66M	$39.79M	$25.90M
Capital Expenditures	-$14.41M	-$7.760M	-$4.500M
Free Cash Flow	$61.07M	$47.55M	$30.40M
YoY Change	100.89%	138.35%	29.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35060
	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Sylvan Way, Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Parsippany
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07054
	dei	City Area Code CityAreaCode	973
	dei	Local Phone Number LocalPhoneNumber	254-3560
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	PCRX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43443699	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125244000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2020Q3	us-gaap	Short Term Investments ShortTermInvestments	406881000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	213722000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46143000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47530000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	68542000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11710000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10781000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	658520000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	408557000	USD
CY2020Q3	us-gaap	Long Term Investments LongTermInvestments	44062000	USD
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	64798000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	125527000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	76047000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38124000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	99547000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	98487000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	104387000	USD
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	104122000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q3	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	13957000	USD
CY2019Q4	pcrx	Equity Method Investments And Other Assets EquityMethodInvestmentsAndOtherAssets	10971000	USD
CY2020Q3	us-gaap	Assets Assets	1220269000	USD
CY2019Q4	us-gaap	Assets Assets	831065000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13008000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12799000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60403000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70427000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7455000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4935000	USD
CY2020Q3	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	5406000	USD
CY2019Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	18179000	USD
CY2020Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1333000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	86272000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107673000	USD
CY2020Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	456464000	USD
CY2019Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	306045000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72448000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40938000	USD
CY2020Q3	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	16176000	USD
CY2019Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	19963000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4219000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1502000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	635579000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	476121000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43312638	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43312638	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41908148	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41908148	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	43000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	852190000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	753978000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-268390000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399398000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	847000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	322000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	584690000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1220269000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	831065000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	117484000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	104685000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	298673000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	298602000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	29993000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	22304000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	82031000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	74809000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14651000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20255000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44090000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52466000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	52561000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50128000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	140683000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	146559000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1967000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1967000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3736000	USD
CY2020Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-692000	USD
CY2019Q3	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-7618000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	1599000	USD
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-12266000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	99864000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	102272000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	271105000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	289836000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	17620000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2413000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	27568000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	8766000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1025000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1736000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3936000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5709000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	7132000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	5940000	USD
	us-gaap	Interest Expense InterestExpense	18609000	USD
	us-gaap	Interest Expense InterestExpense	17631000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2708000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4025000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2571000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4051000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11470000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8229000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20173000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15973000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6150000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5816000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7395000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7207000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-123969000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	271000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-123613000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1079000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	130119000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6128000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.94
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42928000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41645000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42393000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41423000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44275000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41645000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43333000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41423000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	130119000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6128000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-643000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	525000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	727000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-643000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-53000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	525000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	727000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	129476000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6140000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	131533000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5401000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	388148000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24582000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10954000	USD
CY2020Q3	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20450000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-643000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	130119000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	584690000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	341650000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1408000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9244000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	346162000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	36238000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1421000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29024000	USD
	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20450000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	525000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131008000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	584690000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4995000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1270000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24461000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	727000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6128000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	346162000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6128000	USD
	pcrx	Adjustments From Changes In Deferred Tax Asset Valuation Allowance Increase Decrease AdjustmentsFromChangesInDeferredTaxAssetValuationAllowanceIncreaseDecrease	124572000	USD
	pcrx	Adjustments From Changes In Deferred Tax Asset Valuation Allowance Increase Decrease AdjustmentsFromChangesInDeferredTaxAssetValuationAllowanceIncreaseDecrease	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14847000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14486000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1512000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1273000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12684000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10216000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-998000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	29024000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	24461000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1560000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7327000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-2779000	USD
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3957000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1386000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3567000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10246000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9967000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	382000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2451000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1117000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	829000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16454000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4004000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1670000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-822000	USD
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	9409000	USD
	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30365000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44616000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	118683000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23393000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5662000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	326664000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	220091000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	154767000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	248365000	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1622000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-195290000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97693000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	35980000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4991000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1421000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1270000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	12487000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5591000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	211941000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5690000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	47016000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47387000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78228000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132526000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125244000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85139000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5305000	USD
	us-gaap	Interest Paid Net InterestPaidNet	4102000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2329000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	702000	USD
	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	28470000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	6423000	USD
	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	1663000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	116889000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	104350000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	296850000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	297080000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	27614000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20019000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12080000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14407000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28848000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23870000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	68542000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	209814000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	180121000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	84287000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75440000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	125527000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	3100000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	3600000	USD
	us-gaap	Depreciation Depreciation	8900000	USD
	us-gaap	Depreciation Depreciation	10700000	USD
CY2020Q3	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	66800000	USD
CY2019Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64800000	USD
CY2020Q3	us-gaap	Asset Retirement Obligation AssetRetirementObligation	200000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P9Y10M24D
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	3099000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1585000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	7085000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	4544000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	611000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	403000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	1661000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	1233000	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	3710000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	1988000	USD
	us-gaap	Lease Cost LeaseCost	8746000	USD
	us-gaap	Lease Cost LeaseCost	5777000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	38419000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42101000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	11251000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	5247000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M20D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0688
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4501000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10745000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10423000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10697000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10980000	USD
CY2020Q3	pcrx	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	62072000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	109418000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	29515000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	79903000	USD
CY2020Q3	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99500000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	99500000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11603000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98487000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5703000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	104387000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5900000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2000000.0	USD
CY2020Q3	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period1 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod1	7900000	USD
CY2020Q3	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount Period2 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountPeriod2	2200000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2020Q3	pcrx	Debt Instrument Principal Amount Denominator For Conversion Into Common Stock DebtInstrumentPrincipalAmountDenominatorForConversionIntoCommonStock	1000	USD
CY2020Q3	pcrx	Debt Instrument Principal Amount Denominator For Conversion Into Common Stock DebtInstrumentPrincipalAmountDenominatorForConversionIntoCommonStock	1000	USD
	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
	pcrx	Amortization Period Of Transaction Costs Attributable To Liability Component Of Convertible Debt AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt	P5Y
	pcrx	Transaction Costs Attributable To The Equity Component Of Convertible Debt TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt	2700000	USD
CY2020Q3	pcrx	Debt Instrument Principal Amount Denominator For Conversion Into Common Stock DebtInstrumentPrincipalAmountDenominatorForConversionIntoCommonStock	1000	USD
CY2020Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1764000	USD
CY2019Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2048000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5861000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	6146000	USD
CY2020Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	629000	USD
CY2019Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	429000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1512000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	24000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1273000	USD
CY2020Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5430000	USD
CY2019Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3467000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12684000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10216000	USD
CY2020Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	691000	USD
CY2019Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1448000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	7132000	USD
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	5940000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	18609000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	17631000	USD
CY2020Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0678
CY2019Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0735
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	346000	USD
CY2020Q3	us-gaap	Share Price SharePrice	60.12
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7300000	USD
CY2019Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7300000	USD
CY2020Q3	pcrx	Total Milestone Payments Yet To Be Paidin Connectionwith Myo Science Acquisition TotalMilestonePaymentsYetToBePaidinConnectionwithMyoScienceAcquisition	58000000.0	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	450096000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	858000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	11000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	450943000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	278198000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	278520000	USD
CY2020Q3	us-gaap	Interest Receivable InterestReceivable	1600000	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	1400000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	12800000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10000000.0	USD
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	2800000	USD
CY2020Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	2800000	USD
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10954000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9244000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29024000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24461000	USD
CY2020Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	7181000	USD
CY2019Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6418000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	19795000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	16917000	USD
CY2020Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	3552000	USD
CY2019Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	2639000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	8589000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	6950000	USD
CY2020Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	221000	USD
CY2019Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	187000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	640000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	594000	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	10954000	USD
CY2019Q3	us-gaap	Share Based Compensation ShareBasedCompensation	9244000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	29024000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	24461000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6706378	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	42.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1470003	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	47.27
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1129762	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	32.08
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	403467	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	41.90
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	44177	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	61.63
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6598975	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	45.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	36668	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	130119000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6128000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42928000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41645000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42393000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41423000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44275000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41645000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43333000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41423000	shares
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.03
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.94
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3615000	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4894000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4993000	shares
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	8175000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3205000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	10154000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2183000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2025000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2611000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2759000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5024000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6150000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5816000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7395000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7207000	USD
CY2020Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	603000	USD
CY2019Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	271000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	959000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	749000	USD
CY2020Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	603000	USD
CY2019Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	271000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	959000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	749000	USD
CY2020Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-104389000	USD
CY2019Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-104389000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1828000	USD
CY2020Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-20183000	USD
CY2019Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-20183000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-124572000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1257000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-124572000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-123969000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	271000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-123613000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1079000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-124000000.0	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-123600000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1100000	USD
CY2020Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-124600000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-124600000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1800000	USD
CY2020Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-124600000	USD
	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66262000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	68921000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	17197000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	16895000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	16203000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	15778000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8043000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8767000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	22315000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	23187000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1671000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1646000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2022000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	132948000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	137216000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	22215000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8125000	USD
CY2020Q3	pcrx	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	110733000	USD
CY2019Q4	pcrx	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	129091000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6611000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	129091000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	104122000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2019Q3	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2019	pcrx	Litigation Investigation Term LitigationInvestigationTerm	P5Y
CY2019Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3500000	USD

Files In Submission

Name	View Source	Status
0001396814-20-000045-index-headers.html	Edgar Link	pending
0001396814-20-000045-index.html	Edgar Link	pending
0001396814-20-000045.txt	Edgar Link	pending
0001396814-20-000045-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcrx-20200930.htm	Edgar Link	pending
pcrx-20200930.xsd	Edgar Link	pending
pcrx-20200930_cal.xml	Edgar Link	unprocessable
pcrx-20200930_def.xml	Edgar Link	unprocessable
pcrx-20200930_g1.jpg	Edgar Link	pending
pcrx-20200930_htm.xml	Edgar Link	completed
pcrx-20200930_lab.xml	Edgar Link	unprocessable
pcrx-20200930_pre.xml	Edgar Link	unprocessable
pcrx-9302020xex311.htm	Edgar Link	pending
pcrx-9302020xex312.htm	Edgar Link	pending
pcrx-9302020xex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2020 Q4 Form 10-Q Financial Statement

#000139681420000045 Filed on October 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2020 Q4 Form 10-Q Financial Statement

#000139681420000045 Filed on October 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx